APA (7th ed.) Citation

Soverini, S., Martelli, M., Bavaro, L., De Benedittis, C., Sica, S., Sorà, F., . . . Cavo, M. (2021). BCR-ABL1 compound mutants: Prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS. Leukemia, 35(7), 2102-2107. https://doi.org/10.1038/s41375-020-01098-w

Chicago Style (17th ed.) Citation

Soverini, Simona, et al. "BCR-ABL1 Compound Mutants: Prevalence, Spectrum and Correlation with Tyrosine Kinase Inhibitor Resistance in a Consecutive Series of Philadelphia Chromosome-positive Leukemia Patients Analyzed by NGS." Leukemia 35, no. 7 (2021): 2102-2107. https://doi.org/10.1038/s41375-020-01098-w.

MLA (9th ed.) Citation

Soverini, Simona, et al. "BCR-ABL1 Compound Mutants: Prevalence, Spectrum and Correlation with Tyrosine Kinase Inhibitor Resistance in a Consecutive Series of Philadelphia Chromosome-positive Leukemia Patients Analyzed by NGS." Leukemia, vol. 35, no. 7, 2021, pp. 2102-2107, https://doi.org/10.1038/s41375-020-01098-w.